4-methoxyamphetamine has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katsimardos, A; Kosmas, N; Kountouri, A; Rallidi, T; Rallidis, LS; Varounis, C; Zapantiotis, D | 1 |
| Daida, H; Dohi, T; Kajimoto, K; Kasai, T; Kojima, T; Kubota, N; Kurata, T; Miyauchi, K; Tamura, H; Yokoyama, K; Yokoyama, T | 1 |
2 other study(ies) available for 4-methoxyamphetamine and Metabolic Syndrome
| Article | Year |
|---|---|
Differential prognostic value of resistin for cardiac death in patients with coronary artery disease according to the presence of metabolic syndrome.
Topics: Biomarkers; C-Reactive Protein; Coronary Artery Disease; Death; Humans; Interleukin-6; Metabolic Syndrome; Prognosis; Resistin; Risk Factors | 2022 |
Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Death; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Myocardial Revascularization; Proportional Hazards Models; Survival Rate; Treatment Outcome | 2009 |